Not yet recruitingPhase 2NCT06084780
Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
Studying Pseudomyxoma peritonei
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Case Comprehensive Cancer Center
- Principal Investigator
- Masato Fujiki, MD, PhDCleveland Clinic Digestive Disease & Surgery Institute (DDSI) , Case Comprehensive Cancer Center
- Intervention
- Intestinal, Multivisceral or Modified Multivisceral Transplantation(procedure)
- Enrollment
- 20 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2026 – 2026
Study locations (1)
- Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06084780 on ClinicalTrials.govOther trials for Pseudomyxoma peritonei
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07328737One vs Three HIPEC Cycles After CRS for Pseudomyxoma PeritoneiBeijing Tsinghua Chang Gung Hospital
- RECRUITINGEARLY PHASE1NCT07341360Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma PeritoneiOslo University Hospital
- RECRUITINGNCT02073500Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesOslo University Hospital